Literature DB >> 22828014

Age-related changes in brain metabolites and cognitive function in APP/PS1 transgenic mice.

Shuang-qing Chen1, Qing Cai, Yu-ying Shen, Pei-jun Wang, Gao-jun Teng, Wei Zhang, Feng-chao Zang.   

Abstract

Proton magnetic resonance spectroscopy ((1)H-MRS) and the Morris water maze (MWM) have played an important role in Alzheimer's disease (AD) research. The aim of this study was to determine whether (1)H-MRS and the MWM can detect for early AD in APP/PS1 transgenic (tg) mice. (1)H-MRS was performed in 20 tg mice and 15 wild-type mice at 3, 5 and 8 months of age. The concentration of N-acetylaspartate (NAA), glutamate (Glu), myo-inositol (mI), choline (Cho) and creatine (Cr) in the hippocampus were measured, and the NAA/Cr, Glu/Cr, mI/Cr and Cho/Cr ratios were quantified. Additionally, the spatial learning and memory of the mice were evaluated by MWM. The (1)H-MRS revealed that mI levels in tg mice were significantly higher at 3 months of age compared to wt mice, while the NAA and Glu levels in 5- and 8-month-old tg mice were significantly decreased (p<0.05). Additionally, significant cognitive changes only occurred at 8 months of age in APP/PS1 tg mice. These results indicated that metabolic changes preceded overt cognitive dysfunctions in early-stage AD, suggesting that (1)H-MRS is a more sensitive biomarker for assessing early AD.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22828014     DOI: 10.1016/j.bbr.2012.07.016

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  23 in total

1.  Circular HDAC9/microRNA-138/Sirtuin-1 Pathway Mediates Synaptic and Amyloid Precursor Protein Processing Deficits in Alzheimer's Disease.

Authors:  Yanjun Lu; Lu Tan; Xiong Wang
Journal:  Neurosci Bull       Date:  2019-03-18       Impact factor: 5.203

2.  3T hippocampal glutamate-glutamine complex reflects verbal memory decline in aging.

Authors:  Simona Nikolova; Shauna M Stark; Craig E L Stark
Journal:  Neurobiol Aging       Date:  2017-03-18       Impact factor: 4.673

3.  Treatment effects in a transgenic mouse model of Alzheimer's disease: a magnetic resonance spectroscopy study after passive immunization.

Authors:  M Marjańska; S D Weigand; G Preboske; T M Wengenack; R Chamberlain; G L Curran; J F Poduslo; M Garwood; D Kobayashi; J C Lin; C R Jack
Journal:  Neuroscience       Date:  2013-12-04       Impact factor: 3.590

4.  Transcriptional regulation of N-acetylaspartate metabolism in the 5xFAD model of Alzheimer's disease: evidence for neuron-glia communication during energetic crisis.

Authors:  Samantha Zaroff; Paola Leone; Vladimir Markov; Jeremy S Francis
Journal:  Mol Cell Neurosci       Date:  2015-03-10       Impact factor: 4.314

5.  Altered Expression of Small Intestinal Drug Transporters and Hepatic Metabolic Enzymes in a Mouse Model of Familial Alzheimer's Disease.

Authors:  Yijun Pan; Kotaro Omori; Izna Ali; Masanori Tachikawa; Tetsuya Terasaki; Kim L R Brouwer; Joseph A Nicolazzo
Journal:  Mol Pharm       Date:  2018-08-22       Impact factor: 4.939

6.  Cortical metabolic deficits in a rat model of cholinergic basal forebrain degeneration.

Authors:  Francesca Gelfo; Laura Petrosini; Alessandro Graziano; Paola De Bartolo; Lorena Burello; Emilia Vitale; Arianna Polverino; Antonietta Iuliano; Giuseppe Sorrentino; Laura Mandolesi
Journal:  Neurochem Res       Date:  2013-08-08       Impact factor: 3.996

7.  Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.

Authors:  Aisling M Chaney; Francisco R Lopez-Picon; Sophie Serrière; Rui Wang; Daniela Bochicchio; Samuel D Webb; Matthias Vandesquille; Michael K Harte; Christina Georgiadou; Catherine Lawrence; Julie Busson; Johnny Vercouillie; Clovis Tauber; Frédéric Buron; Sylvain Routier; Tristan Reekie; Anniina Snellman; Michael Kassiou; Johanna Rokka; Karen E Davies; Juha O Rinne; Dervis A Salih; Frances A Edwards; Llwyd D Orton; Stephen R Williams; Sylvie Chalon; Hervé Boutin
Journal:  Theranostics       Date:  2021-05-03       Impact factor: 11.556

8.  Magnetic resonance spectroscopy in Alzheimer's disease.

Authors:  Jonathan Graff-Radford; Kejal Kantarci
Journal:  Neuropsychiatr Dis Treat       Date:  2013-05-16       Impact factor: 2.570

9.  A longitudinal study of cognition, proton MR spectroscopy and synaptic and neuronal pathology in aging wild-type and AβPPswe-PS1dE9 mice.

Authors:  Diane Jansen; Valerio Zerbi; Carola I F Janssen; Pieter J W C Dederen; Martina P C Mutsaers; Anne Hafkemeijer; Anna-Lena Janssen; Cindy L M Nobelen; Andor Veltien; Jack J Asten; Arend Heerschap; Amanda J Kiliaan
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

10.  Effects of specific multi-nutrient enriched diets on cerebral metabolism, cognition and neuropathology in AβPPswe-PS1dE9 mice.

Authors:  Diane Jansen; Valerio Zerbi; Ilse A C Arnoldussen; Maximilian Wiesmann; Anne Rijpma; Xiaotian T Fang; Pieter J Dederen; Martina P C Mutsaers; Laus M Broersen; Dieter Lütjohann; Malgorzata Miller; Leo A B Joosten; Arend Heerschap; Amanda J Kiliaan
Journal:  PLoS One       Date:  2013-09-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.